Cancer trials often involve life-threatening conditions, making it crucial to monitor the efficacy and safety of new treatments closely. The O'Brien Fleming method allows researchers to perform interim analyses without inflating the probability of making false-positive conclusions. This statistical rigor is essential for maintaining the integrity of the trial and ensuring that any positive outcomes are genuinely due to the intervention being tested.
